Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Alings

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
Trials|December 25, 2009
Rationale and design of WEBCARE: a randomized, controlled, web-based behavioral intervention trial in cardioverter-defibrillator patients to reduce anxiety and device concerns and enhance quality of lifeSusanne S Pedersen, Viola Spek, Dominic A M J Theuns, et al.
Hand (New York, N.Y.)|March 5, 2022
Treatment and Management of Upper Extremity Dysfunction Following Transradial Percutaneous Coronary Intervention: A Prospective Cohort StudyElena S Cheung, Eva M Zwaan, Ton A R Schreuders, et al.
Journal of Cardiovascular Electrophysiology|February 11, 2026
Self-Administered Etripamil Nasal Spray Slows Ventricular Rate in Patients With Atrial Fibrillation: A Post Hoc Analysis of the NODE-303 StudyPaul Dorian, Marco Alings, Benoit Coutu, et al.
The American Journal of Cardiology|August 9, 2011
Effect of cardiac resynchronization therapy-defibrillator implantation on health status in patients with mild versus moderate symptoms of heart failureHenneke Versteeg, Krista C van den Broek, Dominic A M J Theuns, et al.
Annals of Internal Medicine|November 16, 2011
Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trialJonas Oldgren, Marco Alings, Harald Darius, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|February 14, 2017
Web-based distress management for implantable cardioverter defibrillator patients: A randomized controlled trialMirela Habibović, Johan Denollet, Pim Cuijpers, et al.
Journal of the American College of Cardiology|February 16, 2013
Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation)Hessel F Groenveld, Jan G P Tijssen, Harry J G M Crijns, et al.
European Heart Journal|April 19, 2013
Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trialSana M Al-Khatib, Laine Thomas, Lars Wallentin, et al.
Lancet (London, England)|August 31, 2010
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trialLars Wallentin, Salim Yusuf, Michael D Ezekowitz, et al.
Circulation|May 4, 2019
Individual Treatment Effect Estimation of 2 Doses of Dabigatran on Stroke and Major Bleeding in Atrial FibrillationManon C Stam-Slob, Stuart J Connolly, Yolanda van der Graaf, et al.
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Trials|December 25, 2009
Rationale and design of WEBCARE: a randomized, controlled, web-based behavioral intervention trial in cardioverter-defibrillator patients to reduce anxiety and device concerns and enhance quality of lifeSusanne S Pedersen, Viola Spek, Dominic A M J Theuns, et al.
Hand (New York, N.Y.)|March 5, 2022
Treatment and Management of Upper Extremity Dysfunction Following Transradial Percutaneous Coronary Intervention: A Prospective Cohort StudyElena S Cheung, Eva M Zwaan, Ton A R Schreuders, et al.
Journal of Cardiovascular Electrophysiology|February 11, 2026
Self-Administered Etripamil Nasal Spray Slows Ventricular Rate in Patients With Atrial Fibrillation: A Post Hoc Analysis of the NODE-303 StudyPaul Dorian, Marco Alings, Benoit Coutu, et al.
The American Journal of Cardiology|August 9, 2011
Effect of cardiac resynchronization therapy-defibrillator implantation on health status in patients with mild versus moderate symptoms of heart failureHenneke Versteeg, Krista C van den Broek, Dominic A M J Theuns, et al.
Annals of Internal Medicine|November 16, 2011
Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trialJonas Oldgren, Marco Alings, Harald Darius, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|February 14, 2017
Web-based distress management for implantable cardioverter defibrillator patients: A randomized controlled trialMirela Habibović, Johan Denollet, Pim Cuijpers, et al.
Journal of the American College of Cardiology|February 16, 2013
Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation)Hessel F Groenveld, Jan G P Tijssen, Harry J G M Crijns, et al.
European Heart Journal|April 19, 2013
Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trialSana M Al-Khatib, Laine Thomas, Lars Wallentin, et al.
Lancet (London, England)|August 31, 2010
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trialLars Wallentin, Salim Yusuf, Michael D Ezekowitz, et al.
Circulation|May 4, 2019
Individual Treatment Effect Estimation of 2 Doses of Dabigatran on Stroke and Major Bleeding in Atrial FibrillationManon C Stam-Slob, Stuart J Connolly, Yolanda van der Graaf, et al.
Pageof 13